ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · IEX Real-Time Price · USD
16.87
+0.65 (4.01%)
At close: Apr 25, 2024, 4:00 PM
17.03
+0.16 (0.95%)
After-hours: Apr 25, 2024, 6:29 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $851.91 million as of April 25, 2024. Its market cap has increased by 347.43% in one year.
Market Cap
851.91M
Enterprise Value
678.82M
1-Year Change
347.43%
Ranking
Category
Stock Price
$16.87
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.04B to $851.91M, a decrease of -18.19%. That is a compound annual growth rate of -5.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 813.50M | 4.64% |
Apr 23, 2024 | 777.40M | 8.93% |
Apr 22, 2024 | 713.70M | -8.78% |
Apr 19, 2024 | 782.40M | -0.89% |
Apr 18, 2024 | 789.40M | -2.11% |
Apr 17, 2024 | 806.40M | 10.97% |
Apr 16, 2024 | 726.70M | 12.41% |
Apr 15, 2024 | 646.50M | -1.07% |
Apr 12, 2024 | 653.50M | -2.61% |
Apr 11, 2024 | 671.00M | 11.04% |
Apr 10, 2024 | 604.30M | -2.36% |
Apr 9, 2024 | 618.90M | 1.66% |
Apr 8, 2024 | 608.80M | -0.75% |
Apr 5, 2024 | 613.40M | 8.82% |
Apr 4, 2024 | 563.70M | 4.08% |
Apr 3, 2024 | 541.60M | 0.74% |
Apr 2, 2024 | 537.60M | -2.73% |
Apr 1, 2024 | 552.70M | -1.16% |
Mar 28, 2024 | 559.20M | -2.27% |
Mar 27, 2024 | 572.20M | 1.96% |
Mar 26, 2024 | 561.20M | -4.53% |
Mar 25, 2024 | 587.80M | -0.17% |
Mar 22, 2024 | 588.80M | -6.15% |
Mar 21, 2024 | 627.40M | 4.25% |
Mar 20, 2024 | 601.80M | 3.79% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Pediatrix Medical Group | 790.76M |
Mobile-health Network Solutions | 782.00M |
Autolus Therapeutics | 779.97M |
REGENXBIO | 778.99M |
Sage Therapeutics | 778.38M |
Relay Therapeutics | 773.96M |
BioLife Solutions | 771.01M |
Cytek Biosciences | 760.09M |